Generating Knowledge - Impacting Health
  • Home
  • About
    • Founding
    • Leadership
    • Partner Institutions
    • Research Staff
    • CAPRISA Research
      • Research Activities
    • Research Clinics
    • Policies
    • Awards
    • Financial Statements
  • Research
    • CAPRISA Studies
    • CTU Studies
    • EDCTP-funded studies
  • Scientific Publications
  • Media
    • Press Releases
    • In the Media
    • Covid-19 Weekly Updates
    • News and Events
    • Videos and Podcasts
      • Awards and Messages
      • Corporate Videos
      • Media Interviews
      • Media Podcasts
      • Presentations
      • Events
    • Brochures and Posters
    • Galleries
  • Newsletters
  • Careers
  • Fellowship Programme
  • Alumni
  • Contact

Latest Scientific Publication

Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial

Lancet HIV. 2023;10(4):e230-e243.

30 April 2023

READ MORE

Covid-19 Weekly Updates

READ REPORTS

Latest Scientific Publication

Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial

Lancet HIV. 2023;10(4):e230-e243.

30 April 2023

READ MORE

Covid-19 Weekly Updates

READ REPORTS

CAPRISA NEWS

CAPRISA DSI - NRF Centre of Excellence in HIV Prevention Offers Honours Fellowship for 2024 in HIV Research

15 May 2023

Read more

CAPRISA DSI - NRF Centre of Excellence in HIV Prevention Offers Masters and Doctoral Fellowship in HIV Research for 2024

15 May 2023

Read more

WHO declares end to COVID-19’s emergency phase

10 May 2023

Read more

Dr Sharana Mahomed attends the US National Academy of Medicine’s Emerging Leaders Forum

5 May 2023

Read more

Prof Nigel Garrett appointed Leader of the CAPRISA eThekwini Research Site

4 May 2023

Read more

VIEW MORE NEWS

CAPRISA
CENTRE FOR THE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA

 

CAPRISA was formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York.

CAPRISA is a designated UNAIDS Collaborating Centre for HIV Research and Policy; and is the South African Department of Science and Innovation and the National Research Foundation‘s designated Centre of Excellence in HIV Prevention. Read more

 

DOWNLOAD THE CAPRISA BROCHURE

 

CAPRISA
In The Media

HIV is still a scourge in Africa, especially for women

26 May 2023

COVID-19: What next as shots expire and become harder to get?

22 May 2023

Only the Emergency Has Ended

20 May 2023

MORE ARTICLES

Awards

The Fourth Hideyo Noguchi Africa Prize in Medical Research

READ MORE

University of McMaster Honorary Doctorate

READ MORE

Latest CAPRISA
Newsletter

30 April 2023

DOWNLOAD

ARCHIVES
SUBSCRIBE TO NEWSLETTER

Contact Us | Terms and Conditions | Privacy Policy |Legal | The CAPRISA name logo is a registered Trademark Copyright © 2023 Developed by Loud Crowd Media. All rights reserved

We use cookies to make your experience with us better. By continuing to use our website, you are agreeing to our use of cookies. To find out more see our privacy policy.

Close